HER2 genetic heterogeneity was defined as the presence of ≥5% to <50% of invasive tumor cells with a ratio ≥ 2.2 when using dual probes or ≥6 HER2 signals/cell using single probes. This evidence concerns the gene ERBB2 and neoplasm.